查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599295

病毒惰性市場：按產品、方法、應用和最終用戶分類 - 全球預測 2025-2030

Viral Inactivation Market by Product (Kits & Reagents, Services, Viral Inactivation Systems & Accessories), Method (Pasteurization, Solvent Detergent Method), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年病毒惰性市場價值為9.7741億美元，預計到2024年將達到11.1948億美元，複合年成長率為14.62%，預計到2030年將達到25.4174億美元。

病毒惰性是生物製藥和醫療保健中的重要過程，旨在中和生技藥品、疫苗和血液製品中潛在的病毒污染物。這個過程對於確保藥品安全性和有效性以及保護公眾健康至關重要。此外，其應用涵蓋製藥、生物技術、輸血和診斷實驗室等各個領域，最終用途為醫院、診斷中心、研究機構等。市場的主要驅動力是生物安全監管標準的不斷提高以及對有效和安全治療藥物的需求不斷增加。此外，溶劑/清潔劑處理、巴氏殺菌、低 pH 值處理和紫外線照射等技術的進步，能夠可靠地惰性病毒，也支持了成長。此外，慢性病盛行率的增加和對個人化醫療的日益關注也擴大了病毒惰性應用的潛力。然而，高營運成本、技術複雜性和嚴格的監管合規性等挑戰可能會阻礙市場成長。特別是在新興經濟體，由於不同的法規和基礎設施差異，市場面臨地理限制。機會在於採用創新技術和開發多模態去活化平台，可擴大應用範圍並提高製程效率。探索更有效、更具成本效益的方法和技術，以適應更新、更具抗藥性的病毒株，對於促進成長至關重要。企業應優先投資策略夥伴關係和研發，以有效利用這些機會。儘管市場前景廣闊，但複雜的監管環境以及與流程相關的變更對產品品質產生負面影響的可能性仍然是主要障礙。總體而言，透過創新保持領先地位並適應不斷變化的監管標準，同時確保成本效益，是希望在病毒惰性市場取得成功的公司的關鍵策略。

主要市場統計
基準年[2023] 97741萬美元
預測年份 [2024] 111,948萬美元
預測年份 [2030] 25.4174億美元
複合年成長率（%） 14.62%

市場動態：快速發展的病毒惰性市場的關鍵市場洞察

供需的動態交互作用正在改變病毒惰性市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 世界慢性病的增加
    • 政府加大對製藥和生技產業的支持
    • 新藥認證數量增加
  • 市場限制因素
    • 與製造生物相似藥相關的高成本
  • 市場機會
    • 病毒惰性程序中的技術整合
    • 生命科學產業大力研發投入
  • 市場挑戰
    • 嚴格的政府監管指引

波特五力：駕馭病毒惰性市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對病毒惰性市場的影響

外部宏觀環境因素在塑造病毒惰性市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解病毒惰性市場的競爭狀況

對病毒惰性市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣病毒惰性市場廠商績效評估

FPNV定位矩陣是評估病毒惰性市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製病毒惰性市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對病毒惰性市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性病流行
      • 政府加大對製藥和生物技術產業的支持
      • 新藥認證數量增加
    • 抑制因素
      • 與製造生物相似藥相關的高成本
    • 機會
      • 病毒惰性程序中的技術整合
      • 生命科學產業強勁的研發投入
    • 任務
      • 嚴格的政府監管指引
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章病毒惰性市場：依產品

  • 試劑套件和試劑
  • 服務
  • 病毒惰性系統及配件

第7章病毒惰性市場：依方法分類

  • 消毒
  • 清潔劑洗滌法

第8章病毒惰性市場：依應用

  • 血液和血液製品
  • 細胞/基因療法產品
  • 幹細胞產品
  • 紙巾和紙巾產品
  • 疫苗和治療

第9章病毒惰性市場：依最終用戶分類

  • 學術研究所
  • 合約調查機構
  • 製藥和生物技術公司

第10章美洲病毒惰性市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區病毒惰性市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲病毒惰性市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Cytiva by Danaher Corporation
  • Eurofins Scientific（Ireland）Limited
  • HiMedia Laboratories, LLC
  • Lonza Group Ltd.
  • Merck KGaA
  • Parker Hannifin Corporation
  • PromoCell GmbH
  • Rad Source Technologies, Inc.
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • WuXi AppTec Co., Ltd.
Product Code: MRR-034B5003039F

The Viral Inactivation Market was valued at USD 977.41 million in 2023, expected to reach USD 1,119.48 million in 2024, and is projected to grow at a CAGR of 14.62%, to USD 2,541.74 million by 2030.

Viral inactivation is a critical process in biopharmaceutical manufacturing and healthcare, designed to neutralize potential viral contaminants in biologics, vaccines, and blood products. This process is essential for ensuring the safety and efficacy of pharmaceutical products, thereby protecting public health. Moreover, its application spans various fields, including pharmaceuticals, biotechnology, blood transfusion, and diagnostic laboratories, with end-use sectors comprising hospitals, diagnostic centers, and research institutions. The market is primarily driven by increasing regulatory standards for biologic safety and the rising demand for effective and safe therapeutics. Growth is further propelled by advancements in technologies such as solvent/detergent treatment, pasteurization, low pH treatment, and UV irradiation, enabling reliable viral inactivation. Additionally, the escalating prevalence of chronic diseases and increased focus on personalized medicine have expanded the potential for viral inactivation applications. However, challenges such as high operational costs, technical complexities, and stringent regulatory compliance may hamper market growth. The market faces geographical limitations due to varying regulations and infrastructure disparities, particularly in developing economies. Opportunities lie in adopting innovative technologies and developing multimodal inactivation platforms, which can broaden applicability and enhance process efficiency. Research into more efficient, cost-effective methods, and technologies that can handle newer and more resistant viral strains are imperative for driving growth. Companies should prioritize strategic partnerships and investment in R&D to harness these opportunities effectively. Despite the promising nature of the market, the intricate regulatory landscape and the possible adverse effects on product quality due to process-induced alterations remain significant hurdles. Overall, staying ahead through innovation and adapting to evolving regulatory standards while ensuring cost-effectiveness are key strategies for businesses aiming to thrive in the viral inactivation market.

KEY MARKET STATISTICS
Base Year [2023] USD 977.41 million
Estimated Year [2024] USD 1,119.48 million
Forecast Year [2030] USD 2,541.74 million
CAGR (%) 14.62%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Viral Inactivation Market

The Viral Inactivation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the global prevalence of chronic diseases
    • Growing government support for pharmaceutical & biotechnology industries
    • Rising number of new drug approvals
  • Market Restraints
    • High costs associated with the manufacture of biosimilar products
  • Market Opportunities
    • Technological integrations in viral inactivation procedures
    • Strong R&D investments in the life sciences industry
  • Market Challenges
    • Strict government regulatory guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Viral Inactivation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Viral Inactivation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Viral Inactivation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Viral Inactivation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Viral Inactivation Market

A detailed market share analysis in the Viral Inactivation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Viral Inactivation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Viral Inactivation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Viral Inactivation Market

A strategic analysis of the Viral Inactivation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Viral Inactivation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Cytiva by Danaher Corporation, Eurofins Scientific (Ireland) Limited, HiMedia Laboratories, LLC, Lonza Group Ltd., Merck KGaA, Parker Hannifin Corporation, PromoCell GmbH, Rad Source Technologies, Inc., Sartorius AG, Thermo Fisher Scientific Inc, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Viral Inactivation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Kits & Reagents, Services, and Viral Inactivation Systems & Accessories.
  • Based on Method, market is studied across Pasteurization and Solvent Detergent Method.
  • Based on Application, market is studied across Blood & Blood Product, Cellular & Gene Therapy Product, Stem Cell Product, Tissues & Tissue Product, and Vaccines & Therapeutic.
  • Based on End User, market is studied across Academic Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the global prevalence of chronic diseases
      • 5.1.1.2. Growing government support for pharmaceutical & biotechnology industries
      • 5.1.1.3. Rising number of new drug approvals
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with the manufacture of biosimilar products
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological integrations in viral inactivation procedures
      • 5.1.3.2. Strong R&D investments in the life sciences industry
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulatory guidelines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Viral Inactivation Market, by Product

  • 6.1. Introduction
  • 6.2. Kits & Reagents
  • 6.3. Services
  • 6.4. Viral Inactivation Systems & Accessories

7. Viral Inactivation Market, by Method

  • 7.1. Introduction
  • 7.2. Pasteurization
  • 7.3. Solvent Detergent Method

8. Viral Inactivation Market, by Application

  • 8.1. Introduction
  • 8.2. Blood & Blood Product
  • 8.3. Cellular & Gene Therapy Product
  • 8.4. Stem Cell Product
  • 8.5. Tissues & Tissue Product
  • 8.6. Vaccines & Therapeutic

9. Viral Inactivation Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Viral Inactivation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Viral Inactivation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Viral Inactivation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Becton, Dickinson and Company
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Charles River Laboratories International, Inc.
  • 5. Cytiva by Danaher Corporation
  • 6. Eurofins Scientific (Ireland) Limited
  • 7. HiMedia Laboratories, LLC
  • 8. Lonza Group Ltd.
  • 9. Merck KGaA
  • 10. Parker Hannifin Corporation
  • 11. PromoCell GmbH
  • 12. Rad Source Technologies, Inc.
  • 13. Sartorius AG
  • 14. Thermo Fisher Scientific Inc
  • 15. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. VIRAL INACTIVATION MARKET RESEARCH PROCESS
  • FIGURE 2. VIRAL INACTIVATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VIRAL INACTIVATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VIRAL INACTIVATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VIRAL INACTIVATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VIRAL INACTIVATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VIRAL INACTIVATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VIRAL INACTIVATION MARKET DYNAMICS
  • TABLE 7. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY VIRAL INACTIVATION SYSTEMS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PASTEURIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY SOLVENT DETERGENT METHOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY BLOOD & BLOOD PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY STEM CELL PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY TISSUES & TISSUE PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY VACCINES & THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VIRAL INACTIVATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES VIRAL INACTIVATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA VIRAL INACTIVATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM VIRAL INACTIVATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. VIRAL INACTIVATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. VIRAL INACTIVATION MARKET, FPNV POSITIONING MATRIX, 2023